Asterios Deligiannis | Medicine | Best Innovation Award

Published on by Scientific World Research Awards

Best Innovation Award

Asterios Deligiannis

Researcher Information
Affiliation Aristotle University of Thessaloniki
Country Greece
Scopus ID 7003501457
Documents 127
Citations 5,944
h-index 28
Subject Area Chemistry
Event Scientific World Research Awards
ORCID 0000-0001-7765-1897

Asterios Deligiannis is an academic affiliated with Aristotle University of Thessaloniki, Greece. His scholarly record demonstrates extensive research productivity, interdisciplinary collaboration, and sustained scientific contribution. According to available research metrics, he has produced 127 indexed publications, received 5,944 citations, and achieved an h-index of 28, reflecting broad academic visibility and influence across multiple research domains.[1][2]

Abstract

This article presents an overview of the academic achievements of Asterios Deligiannis. His research portfolio encompasses a substantial body of scholarly work, international collaborations, and contributions to scientific knowledge. Available publication metrics indicate 127 indexed documents, 5,944 citations, and an h-index of 28, reflecting sustained research productivity and scholarly influence.[1] His academic activities include participation in international research initiatives, professional organizations, and peer-reviewed publications. These accomplishments demonstrate innovation, research leadership, and measurable scientific impact, supporting consideration for recognition through the Best Innovation Award within an international academic framework.[2]

Keywords

Innovation, Chemistry, Scientific Research, Academic Impact, Research Excellence, Scholarly Contributions.

Introduction

Research innovation is commonly assessed through scientific productivity, influence, and contributions to knowledge development. Academic recognition programs frequently consider publication records, citation performance, and interdisciplinary engagement when evaluating researchers for distinguished awards.[1]

Research Profile

Deligiannis is affiliated with Aristotle University of Thessaloniki and maintains an active ORCID record. His professional activities include academic leadership, international memberships, and participation in collaborative research programs.[2]

Research Contributions

His scholarly contributions span cardiovascular health, exercise-related investigations, rehabilitation studies, and interdisciplinary scientific research. Numerous peer-reviewed publications demonstrate long-term engagement in advancing evidence-based knowledge and innovation.[3]

Publications

The researcher has authored 127 indexed publications and contributed to a broad collection of scientific articles published in international journals. His publication record reflects sustained scholarly activity and extensive collaboration across research communities.[1]

Research Impact

Research influence is demonstrated through 5,944 citations and an h-index of 28. These indicators suggest significant academic visibility and continuing relevance of his publications within scientific literature and research networks.[1]

Award Suitability

The combination of research productivity, scholarly impact, international engagement, and documented scientific contributions supports consideration for the Best Innovation Award. His profile reflects characteristics commonly associated with academic distinction and innovation-oriented recognition.[1]

Conclusion

Asterios Deligiannis has established a substantial academic record characterized by impactful publications, collaborative research activities, and measurable scholarly influence. These achievements provide a strong foundation for recognition within international research award programs.

References

  1. Elsevier. (n.d.). Scopus Author Details: Asterios Deligiannis, Author ID 7003501457. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=7003501457

  2. ORCID. (2026). Asterios Deligiannis ORCID Record.

    https://orcid.org/0000-0001-7765-1897

  3. Deligiannis, A., et al. (2025). Investigating the Role of Exercise in Improving Bone Health Among Elderly Women with Osteopenia.

    https://doi.org/10.3390/jfmk10040451

  4. Deligiannis, A., et al. (2025). Advanced Stress Echocardiography with Cardiopulmonary Exercise Testing After Myocardial Infarction.

    https://doi.org/10.3390/jfmk10040393

  5. Scientific World Research Awards. (n.d.). Official Award Information Portal.

    https://scientificworld.net/

Yoshiya Tanaka | Medicine | Innovative Research Award

Published on by Scientific World Research Awards

Innovative Research Award

Yoshiya Tanaka

Yoshiya Tanaka
Affiliation Hospital of University of Occupational and Environmental Health
Country Japan
Scopus ID 56328279400
Documents 1,326
Citations 50,831
h-index 99
Subject Area Medicine
Event Scientific World Research Awards

Yoshiya Tanaka, Hospital of University of Occupational and Environmental Health, Japan, is recognized for substantial contributions to rheumatology, immunology, and autoimmune disease research. His scholarly output, clinical investigations, and leadership in international collaborations have supported advancements in evidence-based medical practice and therapeutic development.[1]

Abstract

The Innovative Research Award recognizes researchers whose work demonstrates sustained scientific excellence and measurable impact. Yoshiya Tanaka has contributed extensively to rheumatology and clinical immunology through studies on autoimmune diseases, inflammatory mechanisms, biologic therapies, and targeted treatments. His research has informed clinical guidelines, improved disease classification systems, and supported the development of therapeutic strategies for conditions such as systemic lupus erythematosus, rheumatoid arthritis, and IgG4-related disease. With a substantial publication record and broad international collaboration, his work has influenced both academic research and patient care, reflecting the objectives of the Scientific World Research Awards.[1][2]

Keywords

Rheumatology, Clinical Immunology, Autoimmune Diseases, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Biologic Therapy, Translational Medicine.

Introduction

Modern rheumatology depends on interdisciplinary research linking immunology, molecular biology, and clinical practice. Yoshiya Tanaka has participated in investigations that enhanced understanding of inflammatory pathways and treatment approaches for immune-mediated diseases.[3]

Research Profile

As Professor and Chairman in rheumatology and clinical immunology, Tanaka has developed a research portfolio focused on disease mechanisms, therapeutic innovation, and clinical trial leadership. His scholarly record reflects long-term engagement with translational medicine and global collaboration.[1]

Research Contributions

Key contributions include studies supporting lupus classification criteria, IgG4-related disease frameworks, Janus kinase inhibitor development, and biologic treatment evaluation. These efforts have contributed to improved disease assessment and therapeutic decision-making.[2][4]

Publications

  • 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
  • Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
  • Janus Kinase-Targeting Therapies in Rheumatology.

Research Impact

The researcher’s publications have received extensive citations, demonstrating influence across clinical medicine and immunology. Findings from collaborative studies have informed guidelines, therapeutic development, and evidence-based healthcare practices internationally.[1][5]

Award Suitability

The breadth of scientific output, citation performance, clinical relevance, and leadership in collaborative research aligns with the objectives of the Innovative Research Award. His contributions demonstrate sustained scholarly influence and practical significance in medicine.

Conclusion

Yoshiya Tanaka’s career reflects a consistent commitment to advancing knowledge in rheumatology and autoimmune disease research. His achievements support recognition within international scientific award programs and academic communities.

References

  1. Elsevier. (n.d.). Scopus author details: Yoshiya Tanaka, Author ID 56328279400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56328279400
  2. Aringer, M., et al. (2019). 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
    DOI: https://doi.org/10.1002/art.40930
  3. Tanaka, Y., Adams, D.H., & Shaw, S. (1993). T-cell Adhesion Induced by Proteoglycan-Immobilized Cytokine MIP-1β.
    DOI: https://doi.org/10.1038/361079a0
  4. Tanaka, Y., Luo, Y., O’Shea, J.J., & Nakayamada, S. (2022). Janus Kinase-Targeting Therapies in Rheumatology.
    DOI: https://doi.org/10.1038/s41584-021-00726-8
  5. Google Scholar. (2026). Yoshiya Tanaka Citation Profile.
    https://scholar.google.com/citations?user=t_hAg7QAAAAJ&hl=en

Sedanur Güngör | Public Health | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Sedanur Güngör

Sedanur Güngör
Affiliation Gazi University
Country Turkey
Scopus ID 59374926100
Documents 4
Citations 5
h-index 1
Subject Area Public Health
Event Scientific World Research Awards
ORCID 0000-0002-3943-5365

Sedanur Güngör is a researcher affiliated with Gazi University whose academic work contributes to the fields of physiotherapy, rehabilitation sciences, and public health. Her scholarly profile includes studies related to hand rehabilitation, telerehabilitation methods, musculoskeletal disorders, and clinical assessment tools.[1] Through collaborative clinical investigations, her research reflects contemporary approaches in rehabilitation practice and patient-centered physiotherapy applications.[2]

Abstract

Sedanur Güngör has developed an emerging academic profile in public health and physiotherapy research through collaborative investigations focusing on rehabilitation sciences and clinical patient outcomes. Her published studies address telerehabilitation, grip strength evaluation, osteoarthritis, tendon repair, and virtual assessment methods in physiotherapy practice.[2] These contributions demonstrate engagement with evidence-based rehabilitation techniques and modern therapeutic technologies. Her scholarly activities also include psychometric and clinical investigations intended to improve patient care and rehabilitation efficiency.[3] The interdisciplinary nature of her work reflects the evolving integration of digital healthcare systems into rehabilitation sciences.

Keywords

Public Health, Physiotherapy, Rehabilitation Sciences, Telerehabilitation, Hand Therapy, Clinical Research

Introduction

Current rehabilitation sciences increasingly incorporate digital assessment methods and patient-centered therapy models. Sedanur Güngör’s research activity aligns with these developments through investigations involving hand rehabilitation and therapeutic evaluation systems.[2]

Research Profile

Her Scopus-indexed publications and ORCID profile document collaborative studies in physiotherapy and rehabilitation medicine. Research topics include tendon repair rehabilitation, osteoarthritis interventions, and psychometric clinical measurements.[1]

Research Contributions

Her published investigations evaluate rehabilitation effectiveness, virtual goniometric measurements, and radial nerve mobilization outcomes in clinical populations.[3] These studies contribute to evidence-based physiotherapy literature.

Publications

Research Impact

The researcher’s contributions support ongoing advancements in rehabilitation assessment and therapeutic monitoring. Her work demonstrates practical relevance for physiotherapy professionals and clinical rehabilitation researchers.[4]

Award Suitability

Sedanur Güngör’s emerging publication profile, interdisciplinary rehabilitation studies, and contributions to clinical physiotherapy research support her recognition for the Best Researcher Award under the Scientific World Research Awards program.[5]

Conclusion

The academic activities of Sedanur Güngör reflect a developing contribution to rehabilitation sciences and public health research through clinically focused physiotherapy investigations and collaborative scholarly work.

References

  1. ORCID. (2026). Sedanur Güngör researcher profile and scholarly works.
    https://orcid.org/0000-0002-3943-5365?lang=en
  2. Elsevier. (n.d.). Scopus author details: Sedanur Güngör, Author ID 59374926100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59374926100
  3. Güngör, S., et al. (2026). Virtual goniometric measurement in patients with hand and forearm injuries.
    DOI: https://doi.org/10.1080/09638288.2026.2663904
  4. Güngör, S., et al. (2026). Investigation of the effect of radial nerve mobilization on pain, function, and grip strength.
    DOI: https://doi.org/10.1016/j.physio.2026.102328
  5. Scientific World. (2026). Scientific World Research Awards official website.
    https://scientificworld.net/

Charles Dariane | Medicine | Research Excellence Award

Published on by Scientific World Research Awards

Assist. Prof. Dr. Charles Dariane | Medicine | Research Excellence Award

MD PhD | European Hospital Georges Pompidou | France

Assist. Prof. Dr. Charles Dariane is a leading researcher in urologic oncology, focusing on prostate and renal cancer, advanced imaging, and robotic-assisted surgery. His research skills include clinical trials, surgical innovation, and multidisciplinary collaboration. He has contributed to international cancer guidelines and impactful publications. His Scopus metrics include 1,429 citations, 155 documents, and an h-index of 19. His work enhances precision medicine and improves outcomes in modern urological cancer care.

 

Citation Metrics (Scopus)

1429
1000
700
300
0

Citations

1429

Documents

155

h-index

19

Citations

Documents

h-index

View Scopus Profile

Featured Publications

 

Aleksandra Błachnio | Medicine | Research Excellence Award

Published on by Scientific World Research Awards

Prof. Dr. Aleksandra Błachnio | Medicine | Research Excellence Award

Professor | Kazimierz Wielki University | Poland

Prof. Dr. Aleksandra Błachnio is a highly respected scholar in psychology, with a prolific publication record and substantial impact within gerontology, well-being, and social psychology. Her work includes 554 citations, numerous documents (books and articles), and reflects deep commitment to topics such as aging, quality of life in late adulthood, volunteerism among seniors, well-being, life satisfaction across the lifespan, tele-geriatrics, and cross-cultural analysis of psychological health. Her research interests span gerontology and aging psychology, quality-of-life and life-course studies, volunteer activity and social support in old age, psychological adjustment in later life, and mentalization and positive orientation in elderly patients. Among her core research skills are psychometric assessment, longitudinal and cross-sectional survey design, quality-of-life evaluation, social and health psychology methodology, and interdisciplinary analysis of aging and societal change. Her publications such as studies on “health in old age and patient approaches to telemedicine,” “volunteer activity in late adulthood,” and “subjective perception of life-course in old age and youth” showcase her dedication to improving elderly well-being and social inclusion. Her honors include academic recognition as a habilitated doctor in social sciences (psychology), and wide recognition among peers for her contributions to gerontological and social-psychological research. In conclusion, Aleksandra Błachnio stands out as a leading scholar whose enduring research enriches understanding of aging, social participation, and mental health — offering valuable insights for policymakers, healthcare providers, and communities working to enhance quality of life across generations.

Profiles: Scopus | Google Scholar | ResearchGate

Featured Publications

Ziolkowski, A., Blachnio, A., & Pachalska, M. (2015). An evaluation of life satisfaction and health–quality of life of senior citizens. Annals of Agricultural and Environmental Medicine, 22(1). Citations: 47

Litwic-Kaminska, K., Błachnio, A., Kapsa, I., Brzeziński, Ł., Kopowski, J., & others. (2023). Resilience, positivity and social support as perceived stress predictors among university students. International Journal of Environmental Research and Public Health, 20(19), 6892. Citations: 41

Błachnio, A. (2012). Starość non profit. In Wolontariat na Uniwersytetach. Citations: 37

Błachnio, A. (2012). Starość non profit: Wolontariat na Uniwersytetach Trzeciego Wieku w Polsce i na świecie. Wydawnictwo Uniwersytetu Kazimierza Wielkiego. Citations: 37

Błachnio, A. (2019). Potencjał osób w starości: Poczucie jakości życia w procesie starzenia się. Wydawnictwo Uniwersytetu Kazimierza Wielkiego. Citations: 31

Nasser Mousa | Public Health | Best Researcher Award

Published on by Scientific World Research Awards

Prof. Dr. Nasser Mousa | Public Health | Best Paper Award

Professor | Mansoura University | Egypt

Prof. Dr. Nasser Hamed Mousa is a renowned Egyptian medical scientist and hepatologist, serving at the Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, Egypt. With a Scopus record of 1,028 citations, 47 scientific publications, and an h-index of 16, he has made exceptional contributions to the fields of hepatology, gastroenterology, metabolic diseases, and translational medicine. Prof. Mousa earned his M.B.B.Ch., M.Sc., and Ph.D. in Hepatology and Gastroenterology from leading Egyptian medical universities, where he developed a strong foundation in internal medicine and liver pathology. Over the years, he has built an impressive professional career focusing on clinical hepatology, particularly viral hepatitis, liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). His research interests encompass liver disease surveillance, nanomedicine, cancer biology, and metabolic dysfunction-associated steatotic liver disease (MASLD). Notably, his recent studies on individualized HCC risk stratification and gold nanoparticle-mediated cancer therapy have gained international recognition for their innovative clinical and molecular insights. Prof. Mousa’s research skills span molecular diagnostics, clinical trial design, bioinformatics-based network pharmacology, and predictive modeling for liver disease outcomes, reflecting his multidisciplinary expertise. His collaboration with national and international research teams underscores his leadership in evidence-based hepatology. Prof. Mousa has also contributed to advancing precision medicine approaches for patients with chronic liver disease, integrating laboratory science with clinical decision-making. Throughout his career, he has received numerous academic honors and institutional recognitions for his excellence in research, publication impact, and contribution to medical innovation. In conclusion, Prof. Dr. Nasser Hamed Mousa stands as a distinguished figure in liver research, embodying excellence in scientific inquiry, clinical innovation, and academic leadership, while his impactful body of work continues to influence global hepatology and improve patient outcomes in Egypt and worldwide.

Profiles: Scopus | ORCID 

Featured Publications

  1. Mousa, N., Elbaz, S., Elmetwalli, A., Mansour, M., Abdelsalam, M., Abdelaziz, M., Hashem, M., El-Emam, O., El-wakeel, N., Elgamal, A., et al. (2025). A risk stratification score for predicting first episode of upper gastrointestinal bleeding in patients with cirrhosis. Archives of Medical Research.

  2. Mousa, N., Elmetwalli, A., Abdel-Razik, A., Mousa, E., Abdelsalam, M., Elbaz, S., El-wakeel, N., Eldars, W., Gad, E., Arafa, M., et al. (2025, September 15). Periodontitis and metabolic dysfunction-associated steatotic liver disease: Emphasizing the clinical interplay between hepatologists and dentists. Odontology.

  3. Mousa, N., Elbaz, S., Elmetwalli, A., Abdelsalam, M., Abdelkader, E., Wahba, M., Abdelaziz, M., El-Emam, O., El-wakeel, N., Shaheen, M., et al. (2025, April 16). Neutrophil percentage-to-albumin ratio as a predictor of acute kidney injury in cirrhotic patients: A novel approach utilizing artificial intelligence. American Journal of Nephrology.

  4. Shiha, G., Mousa, N., Soliman, R., Mikhail, N. N. H., Elbasiony, M. A., & Khattab, M. (2020, July). Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective study. Journal of Viral Hepatitis.

  5. Elbaz, S., Mousa, N., Besheer, T., Sheta, T., Taha, K., Awad, M., Effat, N., Elgamal, A., & Abdel-Razik, A. (2020, April 2). Malondialdehyde and C-reactive protein as prognostic markers of hepatocellular carcinoma. British Journal of Biomedical Science.

 

Hugh Sampson | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Dr. Hugh Sampson | Medicine | Best Researcher Award

Professor of Pediatrics | Icahn School of Medicine at Mount Sinai | United States

Dr. Hugh A. Sampson, MD, is a distinguished physician-scientist and pediatric immunologist best known for his pioneering contributions in food allergy and immunopathogenesis, and is currently the Kurt Hirschhorn Professor of Pediatrics and Director Emeritus of the Jaffe Food Allergy Institute at the Icahn School of Medicine at Mount Sinai. He earned a B.A. in Biology from Hamilton College in 1971, then obtained his M.D. from SUNY Buffalo in 1975, followed by a pediatric residency at Northwestern University / Children’s Memorial Hospital and an allergy/immunology fellowship at Duke University (1978–1980). Over his career, he has held leadership roles including chairing the Section on Allergy & Immunology of the American Academy of Pediatrics, serving as past President of AAAAI, holding editorial board positions in leading allergy/immunology journals, and directing national food allergy research consortia. His research interests encompass the pathogenesis of food-induced anaphylaxis, the molecular and immunologic characterization of allergenic food proteins and epitopes, genetics and immune regulation in food allergy, development of precision diagnostics (e.g. epitope-specific IgE/IgG4 profiles), and immunotherapy strategies (oral, epicutaneous, sublingual, and biologics such as anti-IgE) as well as novel therapeutic approaches. His research skills include translational and clinical trial design, immunologic assays (e.g. epitope mapping, serologic biomarkers), mechanistic in vitro and in vivo models, bioinformatics integration, large cohort epidemiologic and registry studies, and mentoring interdisciplinary teams. Among his many awards and honors are election to the National Academy of Medicine (Institute of Medicine) in 2003, the Brett Ratner Award from the American Academy of Pediatrics, the Distinguished Scientist Award of AAAAI, memberships in honorary societies (Alpha Omega Alpha, Sigma Xi), and repeated recognitions from Research.com as a top immunology scientist. According to his institutional profile, his h-index (based on Scopus/Pure) is listed at ~85,982 (which appears anomalous and may reflect internal counting metrics), while bibliometric sources more conservatively report an h-index of ~147 with over 800+ publications; traditional citation counts exceed 100,000 across his work. In conclusion, Dr. Sampson’s career exemplifies a remarkable integration of basic immunology and clinical translation: his leadership, mentorship, and sustained high-impact scholarship have shaped the modern field of food allergy research, spawning diagnostic and therapeutic innovations and training generations of investigators in allergy and immunology.

Profiles: Scopus | ORCID 

Featured Publications

  1. Rose, N. R., Milisauskas, V., & Sampson, H. A. (1975). Species-specific tissue antigens. III. Immunological relationships of enzymic antigens in various species. Clinical and Experimental Immunology, 20, 359–370.

  2. Sampson, H. A., & Buckley, R. H. (1981). Human IgE synthesis in vitro: A reassessment. Journal of Immunology, 127, 829–834.

  3. Rich, K. C., Sampson, H. A., Edwards, N. L., & Fox, I. H. (1981). Familial hypogammaglobulinemia with variable serum immunoglobulins: Concordance with lymphocyte ecto-5′-nucleotidase deficiency. American Journal of Diseases of Children, 135, 795–798.

  4. Sampson, H. A., Walchner, A., & Baker, P. (1981). Recurrent pyogenic infections in individuals with absence of the second component of complement. Journal of Clinical Immunology, 2, 39–45.

  5. LoGalbo, P. R., Sampson, H. A., & Buckley, R. H. (1982). Symptomatic giardiasis in three patients with X-linked agammaglobulinemia. Journal of Pediatrics, 101, 78–80.

 

 

Jack Ng Kok Wah | Public Health | Best Researcher Award | 1653

Published on by Scientific World Research Awards

Dr. Jack Ng Kok Wah | Public Health | Best Researcher Award

Senior Lecturer | Multimedia University Cyberjaya | Malaysia

Dr. Jack Ng Kok Wah is an accomplished academic and industry professional with more than three decades of experience across healthcare, banking, education, and marketing, establishing himself as a well-rounded leader in both practice and scholarship. He earned his Ph.D. in Business in 2023 from Universiti Malaya-Wales, where his research explored psychological factors influencing health protective behavior among private healthcare consumers and the mediating role of consumer innovativeness, integrating behavioral science with health and marketing. His academic foundation also includes an MBA in Marketing from Olympia College Kuala Lumpur (2004) and a BA (Hons) in Marketing Management from Stamford College, Petaling Jaya (2001). Professionally, Dr. Jack has served as Marketing Manager in leading organizations such as Sentosa Specialist Hospital Klang, Tung Shin Hospital, Columbia Leisure Group, AmBank, and CIMB Bank, where he specialized in marketing management, digital innovation, and strategic leadership. Transitioning into academia, he is now a Senior Lecturer at Multimedia University, Cyberjaya, Malaysia, where he combines industry expertise with academic rigor to guide future professionals. His research interests encompass digital marketing, consumer behavior, artificial intelligence in healthcare, marketing psychology, and the emerging role of robotics in surgery and e-health solutions. He has published in reputed Scopus- and IEEE-indexed journals, including Frontiers in Public Health, Journal of Robotic Surgery, Food Reviews International, and Journal of Cases on Information Technology, contributing to multidisciplinary areas such as AI-driven healthcare, robotic surgery, fintech, digital learning, and workplace mental health. His research skills include advanced methodologies such as structural equation modeling, digital behavioral analytics, and systematic literature reviews, paired with the ability to link theory to applied practice. He also serves as a peer reviewer for international journals, reflecting his scholarly engagement. Dr. Jack holds the PIKOM Project Leadership Certification (PLC) Associate from the National ICT Association of Malaysia and is active on platforms like Scopus, ResearcherID, and ResearchGate, which strengthen his global visibility. With 25 citations across 10 indexed documents and an h-index of 3, he demonstrates promising research impact for a scholar who entered academia after a successful professional career. In conclusion, Dr. Jack Ng Kok Wah represents a unique blend of industry excellence, academic achievement, and research innovation, making him a strong candidate for honors such as the Best Researcher Award, as his work continues to advance knowledge while delivering meaningful societal impact.

Profiles: Scopus | ORCID | Google Scholar 

Featured Publications

  1. Wah, J.N.K. (2025). Revolutionizing surgery: AI and robotics for precision, risk reduction, and innovation. Journal of Robotic Surgery, 19(1), Article 47.

  2. Wah, J.N.K. (2025). The rise of robotics and AI-assisted surgery in modern healthcare. Journal of Robotic Surgery, 19(1), 311.

  3. Wah, J.N.K. (2025). AI-driven robotic surgery in oncology: Advancing precision, personalization, and patient outcomes. Journal of Robotic Surgery, 19(1), 1–11.

  4. Wah, J.N.K. (2025). Revolutionizing e-Health: The transformative role of AI-powered hybrid chatbots in healthcare solutions. Frontiers in Public Health, 13, Article 1530799.

  5. Ng, J., Wah, K., Fitriana, M., & Arumugam, T. (2023). Assumptions for structure equation modeling (SEM), normality of data distribution analysis & model fit measures. Journal of Clinical Epidemiology & Toxicology, 4(2), 1–5.